IOLCP Q4&FY21 Business Updates
Company Overview -
• Incorporated in 1986, IOLCP is one of the leading Pharmaceuticals company and is a significant player in the field of specialty chemicals with world class facilities
• Largest producer of Ibuprofen and the only company worldwide being backward integrated with ~35% Global share
• Largest producer of Ethyl Acetate at Single Location in India
• 2nd Largest producer of Iso Butyl Benzene (IBB) with ~30% Global share
• Over 20 products are commercialised with 8 products in pipeline
• Debt free company, No debt raised since 2017
• Customer base across 80 countries.
Key Financial Summary -
P&L Statement -
Balance sheet -
Pharmaceuticals Product wise Segmentation -
Chemicals Product wise Segmentation -
Key Financial Numbers -
1. Imports (in crore) - 613 crore
2. Export (in crore) - 1354 crore
3. Debt/equity - 0
4. Pharma EBITDA Margin - 39%
5. Chemical EBITDA Margin - 12%
* Dr. Sanjay Chaturvedi is appointed as CEO.
Shareholding Pattern -
————————————————————————-
Thank you for reading
Comments
Post a Comment